Dare Bioscience, Inc. — Director's Dealing 2016

Jan 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-01-05

Reporting Person: GUIFFRE CHRISTOPHERD T (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-05	Incentive Stock Option (right to buy)	$3.04	A	137000	Acquired	2026-01-04	Common Stock (137000)	Direct

Footnotes

F1: This option was granted on January 5, 2016. The option vests in 48 equal monthly installments over the four year period following the date of
grant.